NASDAQ
LAVA Therapeutics N.V. (LVTX) has a free cash flow growth of 64.59% as of Friday, May 29, 2026. This represents a 138.63% increase compared to its 12-month average of -167.19%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.